February 1, 2025 Imposing Duties to Address the Synthetic Opioid Supply Chain in the People’s Republic of China - Executive Order
- Fact Seeker
- Mar 3
- 2 min read
Summary:
On February 1, 2025, President Donald J. Trump issued an executive order imposing additional tariffs on imports from the People’s Republic of China (PRC) in response to the ongoing synthetic opioid crisis in the United States. The order expands a previously declared national emergency, citing the large number of opioid-related fatalities and the role of PRC-based chemical companies in supplying precursor chemicals used in illicit drug production.
Key Provisions of the Executive Order:
Expansion of National Emergency: The executive order broadens the scope of the national emergency declared in Proclamation 10886, identifying the failure of the PRC government to take sufficient action against chemical suppliers, transnational criminal organizations (TCOs), and money-laundering networks involved in the illicit opioid trade.
Tariffs on Chinese Imports: Effective February 4, 2025, a 10% ad valorem tariff will be imposed on all imports from the PRC. Goods already in transit before February 1, 2025, may be exempt if importers provide proper certification.
Justification for Action: The order cites statistics indicating that synthetic opioid overdoses are the leading cause of death for individuals aged 18 to 45 in the United States, with fentanyl alone causing approximately 75,000 deaths per year. Additionally, over 500,000 pounds of drugs have been seized at the southern border annually in recent years, with over 42,000 pounds seized at the northern border each year on average.
Potential for Additional Measures: If the PRC retaliates by imposing tariffs on U.S. exports or does not take sufficient action to curb the supply of precursor chemicals, the President reserves the authority to increase or expand the tariffs.
Implementation and Oversight: The Secretary of Homeland Security, in coordination with other federal agencies, will oversee the implementation of the tariffs and monitor the PRC’s actions. If the PRC is determined to have taken adequate steps to mitigate the opioid crisis through cooperative enforcement measures, the tariffs may be removed.
Customs and Trade Regulations: The order specifies that the additional tariffs will apply in conjunction with existing duties and fees, restricts duty-free exemptions for affected goods, and mandates that imports subject to tariffs be classified under "privileged foreign status" when entering U.S. foreign trade zones.
Reporting Requirements: Federal agencies, including the Departments of Homeland Security, Treasury, and Commerce, are required to submit periodic reports to Congress regarding the national emergency and the status of the PRC’s actions.
The executive order asserts that the flow of illicit synthetic opioids into the United States constitutes a public health and national security crisis, necessitating immediate action. The measures outlined aim to incentivize the PRC government to take more aggressive action against chemical suppliers and criminal organizations involved in the illicit opioid trade.
Writer's Note: Summary made with the use of AI tools for editing and quick processing, facts checked against the order before publishing.
Comments